Mucins and Pancreatic Cancer

Pancreatic cancer is characterized by an often dramatic outcome (five year survival < 5%) related to a late diagnosis and a lack of efficient therapy. Therefore, clinicians desperately need new biomarkers and new therapeutic tools to develop new efficient therapies. Mucins belong to an ever i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Isabelle Van Seuningen, Nicolas Skrypek, Nicolas Jonckheere
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2010-10-01
Serie:Cancers
Ämnen:
pancreatic cancer
mucin
regulation
biomarker
therapy
Länkar:http://www.mdpi.com/2072-6694/2/4/1794/
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk